Tag: #Global Trends

The U.S. Food and Drug Administration (FDA) has officially cleared Wellcovorin, a decades-old medication, for an exceedingly rare neurological syndrome—a... Read more

The British pharmaceutical giant has agreed to transfer global development and commercialization rights for its experimental drug, linerixibat, to the... Read more

Roche's ambitions to establish a new treatment standard for breast cancer patients faced a significant setback after its promising drug,... Read more

The pharmaceutical giant has reached a pivotal milestone in its mission to replace aging blockbusters with a more potent generation... Read more

The stock market saw a robust rebound among genetic medicine developers, led by UniQure, following the announcement that Vinay Prasad... Read more

Vertex Pharmaceuticals saw its shares surge following positive Phase 3 results for a treatment acquired through a multi-billion dollar deal,... Read more

Following a prolonged legal feud, the Danish pharmaceutical giant and the leading U.S. digital health platform have reached a landmark... Read more

Driven by the unprecedented success of its diabetes and weight-loss franchise, CEO David Ricks received a compensation package totaling $36.7... Read more

In a decisive briefing on March 5, a high-ranking official from the Food and Drug Administration (FDA) challenged recent claims... Read more